Market cap data unavailable. We couldn't positively verify this ticker's market cap is under $500M. Verify independently before trading.
Kelyniam Global, Inc.
- Market Cap
- Unavailable
- Price
- $0.131
- % Change (Daily % change from the live per-ticker quote feed.)
- -9.66%
- Volume
- 500
About
Kelyniam Global, Inc. operates as a medical device manufacturer, providing specialized solutions for patients. The company creates custom prosthetics using computer-aided design (CAD) and manufacturing (CAM) processes, employing advanced medical-grade polymers. Additionally, Kelyniam develops, produces, and supplies specific cranial and craniofacial fixation screws, crucial for the reconstruction of skull and facial structures. Its clientele encompasses health systems, hospitals, sales representatives, surgeons, insurance providers (payors), and individual patients. Established in 2005, the company was originally named Ketner Global Investments, Inc., rebranding to Kelyniam Global, Inc. in December 2007. Kelyniam Global is based in Collinsville, Connecticut.
Quick stats
Shares outstanding—
Computed float2.7M
Float / sharesUnknown
Key info
SectorHealthcare
IndustryMedical - Devices
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001372114
Websitehttps://www.kelyniam.com
AI Summary
AI-generated1/6
standardbullishearnings
Kelyniam Global Announces Q2 2026 Financial Results
Kelyniam Global reported financial results for the six months ended June 30, 2026, with total revenue rising 39.6% year-over-year to $1.9 million.
The company achieved income from operations of $177,970, reversing a prior-year loss of $59,869, while EBITDA grew to $185,287.
Growth was driven by a more than 50% increase in CustomizedBone™ sales and the successful first implantation of the new FusionÔ PEEK + BCP device during the quarter.